000			01798ngm a2200385 a 4500
001			HST1085_1_2
003			UkLoHST
006			m c
007			cr|cna|||a||||
007			vz|czazum
008			080121s2007 enk|||||||||||s|||v|eng d
028	5	0	_a1085 _bHenry Stewart Talks
035			_a(UkLoHST)262
035			_a(UkLU-K)AC000390307
040			_aUkLU-K _beng _cUkLU-K
100	1		_aYu, Ai-Ming. _4spk
245	1	0	_aGenetics of phase I enzymes _h[electronic resource] / _cAi-Ming Yu.
246	3		_aGenetics of phase 1 enzymes
246	3		_aGenetics of phase one enzymes
260			_aLondon : _bHenry Stewart Talks, _c2007.
300			_a1 online resource (1 streaming video file (33 min.) : _bcolor, sound).
490	1		_aPsychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs, _x2056-452X
500			_aAnimated audio-visual presentation with synchronized narration.
500			_aTitle from title frames.
505	0		_aContents: Inter-patient variations caused by Phase I drug metabolizing enzymes -- Genetic polymorphism of CYP2D6 and impact on psychopharmacotherapy -- Metabolism, pharmacokinetics, pharmacodynamics and toxicity -- Pharmacogenetics and pharmacogenomics move towards individualized drug therapy.
506			_aAccess restricted to subscribers.
538			_aMode of access: World Wide Web.
650		2	_aEnzymes _xgenetics.
650		2	_aPharmacogenetics.
650		2	_aPsychopharmacology.
650		2	_aPsychotropic Drugs.
830		0	_aHenry Stewart talks. _pBiomedical & life sciences collection. _pPsychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs.
856	4	0	_uhttps://hstalks.com/bs/262/
856	4	2	_uhttps://hstalks.com/bs/p/35/ _3Series
999			_c77803 _d77803